VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q37368114  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241121000152.0
008     241121nneanz||abbn n and d
035 ‎‡a  (WKP)Q37368114‏
024 ‎‡a  0000-0001-7397-105X‏ ‎‡2  orcid‏
024 ‎‡a  12794088900‏ ‎‡2  scopus‏
035 ‎‡a  (OCoLC)Q37368114‏
100 0 ‎‡a  পল ডি রবিনসন‏ ‎‡c  গবেষক‏ ‎‡9  bn‏
375 ‎‡a  1‏ ‎‡2  iso5218‏
400 0 ‎‡a  Paul D. Robinson‏ ‎‡c  Australian pulmonologist‏ ‎‡9  en‏
400 0 ‎‡a  Paul D Robinson‏ ‎‡c  wetenschapper‏ ‎‡9  nl‏
670 ‎‡a  Author's A pilot study of inhaled dry-powder mannitol during cystic fibrosis-related pulmonary exacerbation.‏
670 ‎‡a  Author's A Systematic Approach to Multiple Breath Nitrogen Washout Test Quality‏
670 ‎‡a  Author's A whisper from the silent lung zone‏
670 ‎‡a  Author's Abbreviated multi-breath washout for calculation of lung clearance index‏
670 ‎‡a  Author's Abnormal preschool Lung Clearance Index (LCI) reflects clinical status and predicts lower spirometry later in childhood in cystic fibrosis‏
670 ‎‡a  Author's Age and height dependence of lung clearance index and functional residual capacity‏
670 ‎‡a  Author's An official American Thoracic Society workshop report: optimal lung function tests for monitoring cystic fibrosis, bronchopulmonary dysplasia, and recurrent wheezing in children less than 6 years of age.‏
670 ‎‡a  Author's Are children just small adults? The differences between paediatric and adult sleep medicine.‏
670 ‎‡a  Author's Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life.‏
670 ‎‡a  Author's Asthma in childhood‏
670 ‎‡a  Author's Automated Quality Control of Forced Oscillation Measurements: Respiratory Artifact Detection with Advanced Feature Extraction.‏
670 ‎‡a  Author's Blue blood‏
670 ‎‡a  Author's Childhood interstitial lung disease due to surfactant protein C deficiency: frequent use and costs of hospital services for a single case in Australia.‏
670 ‎‡a  Author's Chloral hydrate sedation for infant pulmonary function testing‏
670 ‎‡a  Author's Ciclesonide-induced bronchospasm: an important but preventable side effect‏
670 ‎‡a  Author's Clinical characteristics of adult asthma associated with small airway dysfunction‏
670 ‎‡a  Author's Comparison of facemask and mouthpiece interfaces for multiple breath washout measurements‏
670 ‎‡a  Author's Comparison of the utility of multiple breath inert gas washout parameters in cystic fibrosis‏
670 ‎‡a  Author's Complicated 'pneumonia'‏
670 ‎‡a  Author's Congenital diaphragmatic hernia‏
670 ‎‡a  Author's Consensus statement for inert gas washout measurement using multiple- and single- breath tests.‏
670 ‎‡a  Author's Contribution of peripheral airway function to changes in FEV1/FVC and RV/TLC with aging‏
670 ‎‡a  Author's Cystic fibrosis related diabetes: potential pitfalls in the transition from paediatric to adult care‏
670 ‎‡a  Author's Determinants of peripheral airway function in adults with and without asthma.‏
670 ‎‡a  Author's Disease caused by non-tuberculous mycobacteria in children with cystic fibrosis‏
670 ‎‡a  Author's Does asplenia make some immunisations obligatory?‏
670 ‎‡a  Author's Don't write off paediatric asthma action plans just yet.‏
670 ‎‡a  Author's Early intervention for newborns screened for cystic fibrosis‏
670 ‎‡a  Author's Early intervention studies in infants and preschool children with cystic fibrosis: are we ready?‏
670 ‎‡a  Author's Effect of change of body position in spontaneous sleeping healthy infants on SF6-based multiple breath washout‏
670 ‎‡a  Author's Effect of general anesthesia on pulmonary function and clinical status on children with cystic fibrosis‏
670 ‎‡a  Author's Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry.‏
670 ‎‡a  Author's Efficacy and safety of lumacaftor and ivacaftor in patients aged 6-11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled phase 3 trial‏
670 ‎‡a  Author's End-expiratory lung volume remains stable during N2 MBW in healthy sleeping infants‏
670 ‎‡a  Author's Evidence-based management of paediatric primary spontaneous pneumothorax‏
670 ‎‡a  Author's Exercise capacity is not decreased in children who have undergone lung resection early in life for congenital thoracic malformations compared to healthy age-matched children‏
670 ‎‡a  Author's Feasibility of squeezing multiple breath washout testing into busy clinical laboratories‏
670 ‎‡a  Author's Home-based Forced Oscillation Technique Day-to-Day Variability in Pediatric Asthma‏
670 ‎‡a  Author's Impact of lung function interpretation approach on pediatric bronchiolitis obliterans syndrome diagnosis after lung transplantation‏
670 ‎‡a  Author's In vitro and in vivo functional residual capacity comparisons between multiple-breath nitrogen washout devices‏
670 ‎‡a  Author's Increased day-to-day variability of forced oscillatory resistance in poorly controlled or persistent pediatric asthma‏
670 ‎‡a  Author's Increasing Rates of Pediatric Empyema and Disease Severity With Predominance of Serotype 3 S. pneumonia: An Australian Single-center, Retrospective Cohort 2011 to 2018‏
670 ‎‡a  Author's Inert gas washout: theoretical background and clinical utility in respiratory disease‏
670 ‎‡a  Author's Is twice the duration of washout sufficient time between multiple breath nitrogen washout tests?‏
670 ‎‡a  Author's Long-term morbidity of respiratory viral infections during chemotherapy in children with leukaemia‏
670 ‎‡a  Author's Long-term outcomes of children with intermediate sweat chloride values in infancy‏
670 ‎‡a  Author's Lung clearance index in cystic fibrosis subjects treated for pulmonary exacerbations‏
670 ‎‡a  Author's Management of cystic fibrosis-related diabetes in children and adolescents‏
670 ‎‡a  Author's Managing Asthma in Pregnancy‏
670 ‎‡a  Author's Managing Asthma in Pregnancy (MAP) trial: FeNO levels and childhood asthma.‏
670 ‎‡a  Author's Multiple-Breath Washout as a Lung Function Test in Cystic Fibrosis. A Cystic Fibrosis Foundation Workshop Report‏
670 ‎‡a  Author's Multiple breath washout: From Renaissance to Enlightenment?‏
670 ‎‡a  Author's Newer treatments in the management of pediatric asthma‏
670 ‎‡a  Author's Novel methodology to perform sulfur hexafluoride‏
670 ‎‡a  Author's Novel methodology to perform sulfur hexafluoride (SF6)-based multiple-breath wash-in and washout in infants using current commercially available equipment‏
670 ‎‡a  Author's Obesity and its impact on the respiratory system‏
670 ‎‡a  Author's Omalizumab in the management of steroid dependent allergic bronchopulmonary aspergillosis‏
670 ‎‡a  Author's Omalizumab in the management of steroid dependent allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis‏
670 ‎‡a  Author's Paediatric lung transplant outcomes vary with Mycobacterium abscessus complex species.‏
670 ‎‡a  Author's Poor standardisation of plethysmographic specific airways resistance measurement despite widespread use.‏
670 ‎‡a  Author's Preschool Multiple-Breath Washout Testing. An Official American Thoracic Society Technical Statement‏
670 ‎‡a  Author's Procedures to improve the repeatability of forced oscillation measurements in school-aged children.‏
670 ‎‡a  Author's Question 11: How should Allergic Bronchopulmonary Aspergillosis [ABPA] be managed in Cystic Fibrosis?‏
670 ‎‡a  Author's Question 13: Can we predict the need for lung transplantation in children with cystic fibrosis?‏
670 ‎‡a  Author's Question 6: Is there a role for Mannose-Binding Lectin measurement in Cystic Fibrosis management?‏
670 ‎‡a  Author's Question 7: For an infant with an equivocal sweat chloride following newborn screening, how likely is a diagnosis of cystic fibrosis?‏
670 ‎‡a  Author's Real-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteria.‏
670 ‎‡a  Author's Renal complications following lung and heart-lung transplantation‏
670 ‎‡a  Author's Respiratory Artefact Removal in Forced Oscillation Measurements: A Machine Learning Approach.‏
670 ‎‡a  Author's Slow and fast lung compartments in cystic fibrosis measured by nitrogen multiple-breath washout.‏
670 ‎‡a  Author's Specific airway resistance in preschool children: why not panting after all?‏
670 ‎‡a  Author's Spontaneous Pneumothorax in a Young Child With Pulmonary Tuberculosis.‏
670 ‎‡a  Author's Stratifying Cystic Fibrosis Risk for Newborn Screen Infants With Equivocal Sweat Chloride Levels‏
670 ‎‡a  Author's Surgery in nontuberculous mycobacteria pulmonary disease‏
670 ‎‡a  Author's The effect of inert gas choice on multiple breath washout in healthy infants: differences in lung function outcomes and breathing pattern‏
670 ‎‡a  Author's The re-emerging burden of rickets: a decade of experience from Sydney‏
670 ‎‡a  Author's Tuberculosis in children: a tertiary centre perspective‏
670 ‎‡a  Author's Ultrafine Particles from Traffic Emissions and Children's Health (UPTECH) in Brisbane, Queensland (Australia): study design and implementation‏
670 ‎‡a  Author's Update in paediatric asthma management: where is evidence challenging current practice?‏
670 ‎‡a  Author's Use of non-invasive ventilation in children with congenital tracheal stenosis‏
670 ‎‡a  Author's Using index of ventilation to assess response to treatment for acute pulmonary exacerbation in children with cystic fibrosis‏
670 ‎‡a  Author's Utility of single versus multiple breath washout in adult asthma.‏
670 ‎‡a  Author's Variability of lung clearance index in clinically stable cystic fibrosis lung disease in school age children‏
670 ‎‡a  Author's Ventilation inhomogeneities in children with congenital thoracic malformations‏
670 ‎‡a  Author's Ventilation inhomogeneity and NO and CO diffusing capacity in ex-premature school children‏
670 ‎‡a  Author's Viral infections and asthma: an inflammatory interface?‏
909 ‎‡a  (scopus) 12794088900‏ ‎‡9  1‏
909 ‎‡a  (orcid) 000000017397105x‏ ‎‡9  1‏
919 ‎‡a  preschoolmultiplebreathwashouttestinganofficialamericanthoracicsocietytechnicalstatement‏ ‎‡A  Preschool Multiple-Breath Washout Testing. An Official American Thoracic Society Technical Statement‏ ‎‡9  1‏
919 ‎‡a  poorstandardisationofplethysmographicspecificairwaysresistancemeasurementdespitewidespreaduse‏ ‎‡A  Poor standardisation of plethysmographic specific airways resistance measurement despite widespread use.‏ ‎‡9  1‏
919 ‎‡a  paediatriclungtransplantoutcomesvarywithmycobacteriumabscessuscomplexspecies‏ ‎‡A  Paediatric lung transplant outcomes vary with Mycobacterium abscessus complex species.‏ ‎‡9  1‏
919 ‎‡a  omalizumabinthemanagementofsteroiddependentallergicbronchopulmonaryaspergillosisabpacomplicatingcysticfibrosis‏ ‎‡A  Omalizumab in the management of steroid dependent allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis‏ ‎‡9  1‏
919 ‎‡a  omalizumabinthemanagementofsteroiddependentallergicbronchopulmonaryaspergillosis‏ ‎‡A  Omalizumab in the management of steroid dependent allergic bronchopulmonary aspergillosis‏ ‎‡9  1‏
919 ‎‡a  obesityanditsimpactontherespiratorysystem‏ ‎‡A  Obesity and its impact on the respiratory system‏ ‎‡9  1‏
919 ‎‡a  novelmethodologytoperformsulfurhexafluoridesf6basedmultiplebreathwashinandwashoutininfantsusingcurrentcommerciallyavailableequipment‏ ‎‡A  Novel methodology to perform sulfur hexafluoride (SF6)-based multiple-breath wash-in and washout in infants using current commercially available equipment‏ ‎‡9  1‏
919 ‎‡a  novelmethodologytoperformsulfurhexafluoride‏ ‎‡A  Novel methodology to perform sulfur hexafluoride‏ ‎‡9  1‏
919 ‎‡a  newertreatmentsinthemanagementofpediatricasthma‏ ‎‡A  Newer treatments in the management of pediatric asthma‏ ‎‡9  1‏
919 ‎‡a  multiplebreathwashoutfromrenaissancetoenlightenment‏ ‎‡A  Multiple breath washout: From Renaissance to Enlightenment?‏ ‎‡9  1‏
919 ‎‡a  multiplebreathwashoutasalungfunctiontestincysticfibrosisacysticfibrosisfoundationworkshopreport‏ ‎‡A  Multiple-Breath Washout as a Lung Function Test in Cystic Fibrosis. A Cystic Fibrosis Foundation Workshop Report‏ ‎‡9  1‏
919 ‎‡a  managingasthmainpregnancymaptrialfenolevelsandchildhoodasthma‏ ‎‡A  Managing Asthma in Pregnancy (MAP) trial: FeNO levels and childhood asthma.‏ ‎‡9  1‏
919 ‎‡a  managingasthmainpregnancy‏ ‎‡A  Managing Asthma in Pregnancy‏ ‎‡9  1‏
919 ‎‡a  managementofcysticfibrosisrelateddiabetesinchildrenandadolescents‏ ‎‡A  Management of cystic fibrosis-related diabetes in children and adolescents‏ ‎‡9  1‏
919 ‎‡a  lungclearanceindexincysticfibrosissubjectstreatedforpulmonaryexacerbations‏ ‎‡A  Lung clearance index in cystic fibrosis subjects treated for pulmonary exacerbations‏ ‎‡9  1‏
919 ‎‡a  longtermoutcomesofchildrenwithintermediatesweatchloridevaluesininfancy‏ ‎‡A  Long-term outcomes of children with intermediate sweat chloride values in infancy‏ ‎‡9  1‏
919 ‎‡a  longtermmorbidityofrespiratoryviralinfectionsduringchemotherapyinchildrenwithleukaemia‏ ‎‡A  Long-term morbidity of respiratory viral infections during chemotherapy in children with leukaemia‏ ‎‡9  1‏
919 ‎‡a  istwicethedurationofwashoutsufficienttimebetweenmultiplebreathnitrogenwashouttests‏ ‎‡A  Is twice the duration of washout sufficient time between multiple breath nitrogen washout tests?‏ ‎‡9  1‏
919 ‎‡a  inertgaswashouttheoreticalbackgroundandclinicalutilityinrespiratorydisease‏ ‎‡A  Inert gas washout: theoretical background and clinical utility in respiratory disease‏ ‎‡9  1‏
919 ‎‡a  increasingratesofpediatricempyemaanddiseaseseveritywithpredominanceofserotype3spneumoniaanaustraliansinglecenterretrospectivecohort2011to‏ ‎‡A  Increasing Rates of Pediatric Empyema and Disease Severity With Predominance of Serotype 3 S. pneumonia: An Australian Single-center, Retrospective Cohort 2011 to 2018‏ ‎‡9  1‏
919 ‎‡a  increaseddaytodayvariabilityofforcedoscillatoryresistanceinpoorlycontrolledorpersistentpediatricasthma‏ ‎‡A  Increased day-to-day variability of forced oscillatory resistance in poorly controlled or persistent pediatric asthma‏ ‎‡9  1‏
919 ‎‡a  invitroandinvivofunctionalresidualcapacitycomparisonsbetweenmultiplebreathnitrogenwashoutdevices‏ ‎‡A  In vitro and in vivo functional residual capacity comparisons between multiple-breath nitrogen washout devices‏ ‎‡9  1‏
919 ‎‡a  impactoflungfunctioninterpretationapproachonpediatricbronchiolitisobliteranssyndromediagnosisafterlungtransplantation‏ ‎‡A  Impact of lung function interpretation approach on pediatric bronchiolitis obliterans syndrome diagnosis after lung transplantation‏ ‎‡9  1‏
919 ‎‡a  homebasedforcedoscillationtechniquedaytodayvariabilityinpediatricasthma‏ ‎‡A  Home-based Forced Oscillation Technique Day-to-Day Variability in Pediatric Asthma‏ ‎‡9  1‏
919 ‎‡a  feasibilityofsqueezingmultiplebreathwashouttestingintobusyclinicallaboratories‏ ‎‡A  Feasibility of squeezing multiple breath washout testing into busy clinical laboratories‏ ‎‡9  1‏
919 ‎‡a  exercisecapacityisnotdecreasedinchildrenwhohaveundergonelungresectionearlyinlifeforcongenitalthoracicmalformationscomparedtohealthyagematchedchildren‏ ‎‡A  Exercise capacity is not decreased in children who have undergone lung resection early in life for congenital thoracic malformations compared to healthy age-matched children‏ ‎‡9  1‏
919 ‎‡a  evidencebasedmanagementofpaediatricprimaryspontaneouspneumothorax‏ ‎‡A  Evidence-based management of paediatric primary spontaneous pneumothorax‏ ‎‡9  1‏
919 ‎‡a  endexpiratorylungvolumeremainsstableduringn2mbwinhealthysleepinginfants‏ ‎‡A  End-expiratory lung volume remains stable during N2 MBW in healthy sleeping infants‏ ‎‡9  1‏
919 ‎‡a  efficacyandsafetyoflumacaftorandivacaftorinpatientsaged611yearswithcysticfibrosishomozygousforf508delcftrarandomisedplacebocontrolledphase3trial‏ ‎‡A  Efficacy and safety of lumacaftor and ivacaftor in patients aged 6-11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled phase 3 trial‏ ‎‡9  1‏
919 ‎‡a  effectivenessandresponsepredictorsofomalizumabinasevereallergicasthmapopulationwithahighprevalenceofcomorbiditiestheaustralianxolairregistry‏ ‎‡A  Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry.‏ ‎‡9  1‏
919 ‎‡a  effectofgeneralanesthesiaonpulmonaryfunctionandclinicalstatusonchildrenwithcysticfibrosis‏ ‎‡A  Effect of general anesthesia on pulmonary function and clinical status on children with cystic fibrosis‏ ‎‡9  1‏
919 ‎‡a  effectofchangeofbodypositioninspontaneoussleepinghealthyinfantsonsf6basedmultiplebreathwashout‏ ‎‡A  Effect of change of body position in spontaneous sleeping healthy infants on SF6-based multiple breath washout‏ ‎‡9  1‏
919 ‎‡a  earlyinterventionstudiesininfantsandpreschoolchildrenwithcysticfibrosisareweready‏ ‎‡A  Early intervention studies in infants and preschool children with cystic fibrosis: are we ready?‏ ‎‡9  1‏
919 ‎‡a  earlyinterventionfornewbornsscreenedforcysticfibrosis‏ ‎‡A  Early intervention for newborns screened for cystic fibrosis‏ ‎‡9  1‏
919 ‎‡a  dontwriteoffpaediatricasthmaactionplansjustyet‏ ‎‡A  Don't write off paediatric asthma action plans just yet.‏ ‎‡9  1‏
919 ‎‡a  doesaspleniamakesomeimmunisationsobligatory‏ ‎‡A  Does asplenia make some immunisations obligatory?‏ ‎‡9  1‏
919 ‎‡a  diseasecausedbynontuberculousmycobacteriainchildrenwithcysticfibrosis‏ ‎‡A  Disease caused by non-tuberculous mycobacteria in children with cystic fibrosis‏ ‎‡9  1‏
919 ‎‡a  determinantsofperipheralairwayfunctioninadultswithandwithoutasthma‏ ‎‡A  Determinants of peripheral airway function in adults with and without asthma.‏ ‎‡9  1‏
919 ‎‡a  cysticfibrosisrelateddiabetespotentialpitfallsinthetransitionfrompaediatrictoadultcare‏ ‎‡A  Cystic fibrosis related diabetes: potential pitfalls in the transition from paediatric to adult care‏ ‎‡9  1‏
919 ‎‡a  contributionofperipheralairwayfunctiontochangesinfev1fvcandrvtlcwithaging‏ ‎‡A  Contribution of peripheral airway function to changes in FEV1/FVC and RV/TLC with aging‏ ‎‡9  1‏
919 ‎‡a  consensusstatementforinertgaswashoutmeasurementusingmultipleandsinglebreathtests‏ ‎‡A  Consensus statement for inert gas washout measurement using multiple- and single- breath tests.‏ ‎‡9  1‏
919 ‎‡a  congenitaldiaphragmatichernia‏ ‎‡A  Congenital diaphragmatic hernia‏ ‎‡9  1‏
919 ‎‡a  complicatedpneumonia‏ ‎‡A  Complicated 'pneumonia'‏ ‎‡9  1‏
919 ‎‡a  comparisonoftheutilityofmultiplebreathinertgaswashoutparametersincysticfibrosis‏ ‎‡A  Comparison of the utility of multiple breath inert gas washout parameters in cystic fibrosis‏ ‎‡9  1‏
919 ‎‡a  comparisonoffacemaskandmouthpieceinterfacesformultiplebreathwashoutmeasurements‏ ‎‡A  Comparison of facemask and mouthpiece interfaces for multiple breath washout measurements‏ ‎‡9  1‏
919 ‎‡a  clinicalcharacteristicsofadultasthmaassociatedwithsmallairwaydysfunction‏ ‎‡A  Clinical characteristics of adult asthma associated with small airway dysfunction‏ ‎‡9  1‏
919 ‎‡a  ciclesonideinducedbronchospasmanimportantbutpreventablesideeffect‏ ‎‡A  Ciclesonide-induced bronchospasm: an important but preventable side effect‏ ‎‡9  1‏
919 ‎‡a  chloralhydratesedationforinfantpulmonaryfunctiontesting‏ ‎‡A  Chloral hydrate sedation for infant pulmonary function testing‏ ‎‡9  1‏
919 ‎‡a  childhoodinterstitiallungdiseaseduetosurfactantprotein100deficiencyfrequentuseandcostsofhospitalservicesforasinglecaseinaustralia‏ ‎‡A  Childhood interstitial lung disease due to surfactant protein C deficiency: frequent use and costs of hospital services for a single case in Australia.‏ ‎‡9  1‏
919 ‎‡a  blueblood‏ ‎‡A  Blue blood‏ ‎‡9  1‏
919 ‎‡a  automatedqualitycontrolofforcedoscillationmeasurementsrespiratoryartifactdetectionwithadvancedfeatureextraction‏ ‎‡A  Automated Quality Control of Forced Oscillation Measurements: Respiratory Artifact Detection with Advanced Feature Extraction.‏ ‎‡9  1‏
919 ‎‡a  asthmainchildhood‏ ‎‡A  Asthma in childhood‏ ‎‡9  1‏
919 ‎‡a  asthmaandallergypatternsover18yearsafterseverersvbronchiolitisinthe1yearoflife‏ ‎‡A  Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life.‏ ‎‡9  1‏
919 ‎‡a  arechildrenjustsmalladultsthedifferencesbetweenpaediatricandadultsleepmedicine‏ ‎‡A  Are children just small adults? The differences between paediatric and adult sleep medicine.‏ ‎‡9  1‏
919 ‎‡a  officialamericanthoracicsocietyworkshopreportoptimallungfunctiontestsformonitoringcysticfibrosisbronchopulmonarydysplasiaandrecurrentwheezinginchildrenlessthan6yearsofage‏ ‎‡A  An official American Thoracic Society workshop report: optimal lung function tests for monitoring cystic fibrosis, bronchopulmonary dysplasia, and recurrent wheezing in children less than 6 years of age.‏ ‎‡9  1‏
919 ‎‡a  ageandheightdependenceoflungclearanceindexandfunctionalresidualcapacity‏ ‎‡A  Age and height dependence of lung clearance index and functional residual capacity‏ ‎‡9  1‏
919 ‎‡a  abnormalpreschoollungclearanceindexlcireflectsclinicalstatusandpredictslowerspirometrylaterinchildhoodincysticfibrosis‏ ‎‡A  Abnormal preschool Lung Clearance Index (LCI) reflects clinical status and predicts lower spirometry later in childhood in cystic fibrosis‏ ‎‡9  1‏
919 ‎‡a  abbreviatedmultibreathwashoutforcalculationoflungclearanceindex‏ ‎‡A  Abbreviated multi-breath washout for calculation of lung clearance index‏ ‎‡9  1‏
919 ‎‡a  whisperfromthesilentlungzone‏ ‎‡A  A whisper from the silent lung zone‏ ‎‡9  1‏
919 ‎‡a  systematicapproachtomultiplebreathnitrogenwashouttestquality‏ ‎‡A  A Systematic Approach to Multiple Breath Nitrogen Washout Test Quality‏ ‎‡9  1‏
919 ‎‡a  pilotstudyofinhaleddrypowdermannitolduringcysticfibrosisrelatedpulmonaryexacerbation‏ ‎‡A  A pilot study of inhaled dry-powder mannitol during cystic fibrosis-related pulmonary exacerbation.‏ ‎‡9  1‏
919 ‎‡a  viralinfectionsandasthmaaninflammatoryinterface‏ ‎‡A  Viral infections and asthma: an inflammatory interface?‏ ‎‡9  1‏
919 ‎‡a  ventilationinhomogeneityandnoandcodiffusingcapacityinexprematureschoolchildren‏ ‎‡A  Ventilation inhomogeneity and NO and CO diffusing capacity in ex-premature school children‏ ‎‡9  1‏
919 ‎‡a  ventilationinhomogeneitiesinchildrenwithcongenitalthoracicmalformations‏ ‎‡A  Ventilation inhomogeneities in children with congenital thoracic malformations‏ ‎‡9  1‏
919 ‎‡a  variabilityoflungclearanceindexinclinicallystablecysticfibrosislungdiseaseinschoolagechildren‏ ‎‡A  Variability of lung clearance index in clinically stable cystic fibrosis lung disease in school age children‏ ‎‡9  1‏
919 ‎‡a  utilityofsingleversusmultiplebreathwashoutinadultasthma‏ ‎‡A  Utility of single versus multiple breath washout in adult asthma.‏ ‎‡9  1‏
919 ‎‡a  usingindexofventilationtoassessresponsetotreatmentforacutepulmonaryexacerbationinchildrenwithcysticfibrosis‏ ‎‡A  Using index of ventilation to assess response to treatment for acute pulmonary exacerbation in children with cystic fibrosis‏ ‎‡9  1‏
919 ‎‡a  useofnoninvasiveventilationinchildrenwithcongenitaltrachealstenosis‏ ‎‡A  Use of non-invasive ventilation in children with congenital tracheal stenosis‏ ‎‡9  1‏
919 ‎‡a  updateinpaediatricasthmamanagementwhereisevidencechallengingcurrentpractice‏ ‎‡A  Update in paediatric asthma management: where is evidence challenging current practice?‏ ‎‡9  1‏
919 ‎‡a  ultrafineparticlesfromtrafficemissionsandchildrenshealthuptechinbrisbanequeenslandaustraliastudydesignandimplementation‏ ‎‡A  Ultrafine Particles from Traffic Emissions and Children's Health (UPTECH) in Brisbane, Queensland (Australia): study design and implementation‏ ‎‡9  1‏
919 ‎‡a  tuberculosisinchildrenatertiarycentreperspective‏ ‎‡A  Tuberculosis in children: a tertiary centre perspective‏ ‎‡9  1‏
919 ‎‡a  reemergingburdenofricketsadecadeofexperiencefromsydney‏ ‎‡A  The re-emerging burden of rickets: a decade of experience from Sydney‏ ‎‡9  1‏
919 ‎‡a  effectofinertgaschoiceonmultiplebreathwashoutinhealthyinfantsdifferencesinlungfunctionoutcomesandbreathingpattern‏ ‎‡A  The effect of inert gas choice on multiple breath washout in healthy infants: differences in lung function outcomes and breathing pattern‏ ‎‡9  1‏
919 ‎‡a  surgeryinnontuberculousmycobacteriapulmonarydisease‏ ‎‡A  Surgery in nontuberculous mycobacteria pulmonary disease‏ ‎‡9  1‏
919 ‎‡a  stratifyingcysticfibrosisriskfornewbornscreeninfantswithequivocalsweatchloridelevels‏ ‎‡A  Stratifying Cystic Fibrosis Risk for Newborn Screen Infants With Equivocal Sweat Chloride Levels‏ ‎‡9  1‏
919 ‎‡a  spontaneouspneumothoraxinayoungchildwithpulmonarytuberculosis‏ ‎‡A  Spontaneous Pneumothorax in a Young Child With Pulmonary Tuberculosis.‏ ‎‡9  1‏
919 ‎‡a  specificairwayresistanceinpreschoolchildrenwhynotpantingafterall‏ ‎‡A  Specific airway resistance in preschool children: why not panting after all?‏ ‎‡9  1‏
919 ‎‡a  slowandfastlungcompartmentsincysticfibrosismeasuredbynitrogenmultiplebreathwashout‏ ‎‡A  Slow and fast lung compartments in cystic fibrosis measured by nitrogen multiple-breath washout.‏ ‎‡9  1‏
919 ‎‡a  respiratoryartefactremovalinforcedoscillationmeasurementsamachinelearningapproach‏ ‎‡A  Respiratory Artefact Removal in Forced Oscillation Measurements: A Machine Learning Approach.‏ ‎‡9  1‏
919 ‎‡a  renalcomplicationsfollowinglungandheartlungtransplantation‏ ‎‡A  Renal complications following lung and heart-lung transplantation‏ ‎‡9  1‏
919 ‎‡a  reallifeeffectivenessofomalizumabinsevereallergicasthmaabovetherecommendeddosingrangecriteria‏ ‎‡A  Real-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteria.‏ ‎‡9  1‏
919 ‎‡a  question7foraninfantwithanequivocalsweatchloridefollowingnewbornscreeninghowlikelyisadiagnosisofcysticfibrosis‏ ‎‡A  Question 7: For an infant with an equivocal sweat chloride following newborn screening, how likely is a diagnosis of cystic fibrosis?‏ ‎‡9  1‏
919 ‎‡a  question6istherearoleformannosebindinglectinmeasurementincysticfibrosismanagement‏ ‎‡A  Question 6: Is there a role for Mannose-Binding Lectin measurement in Cystic Fibrosis management?‏ ‎‡9  1‏
919 ‎‡a  question13canwepredicttheneedforlungtransplantationinchildrenwithcysticfibrosis‏ ‎‡A  Question 13: Can we predict the need for lung transplantation in children with cystic fibrosis?‏ ‎‡9  1‏
919 ‎‡a  question11howshouldallergicbronchopulmonaryaspergillosisbemanagedincysticfibrosis‏ ‎‡A  Question 11: How should Allergic Bronchopulmonary Aspergillosis [ABPA] be managed in Cystic Fibrosis?‏ ‎‡9  1‏
919 ‎‡a  procedurestoimprovetherepeatabilityofforcedoscillationmeasurementsinschoolagedchildren‏ ‎‡A  Procedures to improve the repeatability of forced oscillation measurements in school-aged children.‏ ‎‡9  1‏
943 ‎‡a  201x‏ ‎‡A  2018‏ ‎‡9  1‏
946 ‎‡a  b‏ ‎‡9  1‏
996 ‎‡2  NLA|000035457227‏
996 ‎‡2  ISNI|0000000117834691‏
996 ‎‡2  BNF|15001587‏
996 ‎‡2  ISNI|0000000030966253‏
996 ‎‡2  CAOONL|ncf11873215‏
996 ‎‡2  LC|no2018133154‏
996 ‎‡2  LC|no 00028213‏
996 ‎‡2  BIBSYS|90932976‏
996 ‎‡2  NUKAT|n 98030005‏
996 ‎‡2  ISNI|0000000497094583‏
996 ‎‡2  W2Z|10046882‏
996 ‎‡2  LC|no2021119905‏
996 ‎‡2  BNC|981058601579106706‏
996 ‎‡2  ISNI|0000000074271269‏
996 ‎‡2  NTA|068015208‏
996 ‎‡2  LC|no 96027255‏
996 ‎‡2  LIH|LNB:_p_I0;=BP‏
996 ‎‡2  CAOONL|ncf11454720‏
996 ‎‡2  BIBSYS|10037874‏
996 ‎‡2  ISNI|000000039945440X‏
996 ‎‡2  LC|n 79016878‏
996 ‎‡2  DNB|1024754049‏
996 ‎‡2  DBC|87097938543911‏
996 ‎‡2  BIBSYS|26905‏
996 ‎‡2  ISNI|000000007402986X‏
996 ‎‡2  CAOONL|ncf11184571‏
996 ‎‡2  ISNI|0000000371167505‏
996 ‎‡2  LC|nb2021010501‏
996 ‎‡2  NTA|068449674‏
996 ‎‡2  BIBSYS|90652323‏
996 ‎‡2  RERO|A003752221‏
996 ‎‡2  RERO|A003752224‏
996 ‎‡2  J9U|987007375808305171‏
996 ‎‡2  ISNI|0000000029604300‏
996 ‎‡2  LC|no2008167742‏
996 ‎‡2  RERO|A025620222‏
996 ‎‡2  LC|nb2019016599‏
996 ‎‡2  ISNI|0000000109317299‏
996 ‎‡2  LIH|LNB:WG_y_;=B_t_‏
996 ‎‡2  DE633|pe30028786‏
996 ‎‡2  LNB|LNC10-000004307‏
996 ‎‡2  ISNI|000000011578888X‏
996 ‎‡2  LC|n 98056251‏
996 ‎‡2  ISNI|0000000499230454‏
996 ‎‡2  ISNI|0000000399894501‏
996 ‎‡2  NTA|068635982‏
996 ‎‡2  NTA|326570268‏
996 ‎‡2  ISNI|0000000435368876‏
996 ‎‡2  N6I|vtls002264059‏
996 ‎‡2  LC|nb2023015504‏
996 ‎‡2  LC|n 2007070009‏
996 ‎‡2  J9U|987007435524205171‏
996 ‎‡2  BNF|14518315‏
996 ‎‡2  NUKAT|n 00074855‏
996 ‎‡2  LC|n 92027545‏
996 ‎‡2  PLWABN|9810609050205606‏
996 ‎‡2  CAOONL|ncf11286379‏
996 ‎‡2  DNB|1239670893‏
996 ‎‡2  LC|n 2005081633‏
996 ‎‡2  LC|no2022025567‏
996 ‎‡2  NII|DA07003302‏
996 ‎‡2  NUKAT|n 96029390‏
996 ‎‡2  J9U|987007364624105171‏
996 ‎‡2  BNF|16959053‏
996 ‎‡2  CAOONL|ncf10253696‏
996 ‎‡2  LC|no2004077454‏
996 ‎‡2  SUDOC|030264146‏
996 ‎‡2  LC|n 91056482‏
996 ‎‡2  ISNI|0000000028068243‏
996 ‎‡2  RERO|A003752217‏
996 ‎‡2  RERO|A003752216‏
996 ‎‡2  LC|n 82258583‏
996 ‎‡2  LC|n 85242533‏
996 ‎‡2  BIBSYS|90563567‏
996 ‎‡2  ISNI|0000000458779133‏
996 ‎‡2  NTA|134388488‏
996 ‎‡2  BIBSYS|90548854‏
996 ‎‡2  ISNI|0000000034012860‏
996 ‎‡2  LC|no2024022103‏
996 ‎‡2  SUDOC|08132104X‏
996 ‎‡2  SUDOC|261610325‏
996 ‎‡2  LC|n 83181731‏
996 ‎‡2  ISNI|0000000377458389‏
996 ‎‡2  SUDOC|220149062‏
996 ‎‡2  CAOONL|ncf11530564‏
996 ‎‡2  LC|no2012085098‏
996 ‎‡2  SUDOC|165866284‏
996 ‎‡2  ISNI|000000010264262X‏
996 ‎‡2  LC|no2021130678‏
996 ‎‡2  BNF|16775709‏
996 ‎‡2  CAOONL|ncf10362018‏
996 ‎‡2  LC|n 83051390‏
996 ‎‡2  BIBSYS|90636414‏
996 ‎‡2  ISNI|0000000024966097‏
996 ‎‡2  DNB|142430234‏
996 ‎‡2  J9U|987007267157605171‏
996 ‎‡2  NTA|287960137‏
996 ‎‡2  NUKAT|n 2003085340‏
996 ‎‡2  LC|n 2014020261‏
996 ‎‡2  CAOONL|ncf11184682‏
996 ‎‡2  BIBSYS|3060651‏
996 ‎‡2  NLA|000036035613‏
996 ‎‡2  SUDOC|273123971‏
996 ‎‡2  BIBSYS|10021405‏
996 ‎‡2  ISNI|0000000094351071‏
996 ‎‡2  LC|nb2021003736‏
996 ‎‡2  BIBSYS|90406561‏
996 ‎‡2  J9U|987007351729305171‏
996 ‎‡2  RERO|A009697499‏
996 ‎‡2  LC|no2018057976‏
996 ‎‡2  W2Z|3030720‏
996 ‎‡2  SUDOC|23780381X‏
996 ‎‡2  CAOONL|ncf10688061‏
996 ‎‡2  SUDOC|164245960‏
996 ‎‡2  LC|n 94114285‏
996 ‎‡2  LC|n 2002151523‏
996 ‎‡2  LC|n 2009050524‏
996 ‎‡2  RERO|A012381098‏
996 ‎‡2  NUKAT|n 2007001938‏
996 ‎‡2  BNF|14221342‏
996 ‎‡2  RERO|A025623258‏
996 ‎‡2  ISNI|000000003269129X‏
996 ‎‡2  BIBSYS|90604346‏
996 ‎‡2  J9U|987007393014705171‏
996 ‎‡2  NII|DA1379401X‏
996 ‎‡2  LC|nb2013000958‏
996 ‎‡2  CAOONL|ncf11237299‏
996 ‎‡2  NDL|00744496‏
996 ‎‡2  LC|n 88184392‏
996 ‎‡2  BIBSYS|90694820‏
996 ‎‡2  ISNI|0000000399322669‏
996 ‎‡2  BNF|18105587‏
996 ‎‡2  NDL|00454418‏
996 ‎‡2  NDL|00454417‏
996 ‎‡2  J9U|987007449435505171‏
996 ‎‡2  NTA|074525689‏
996 ‎‡2  LC|no2011013832‏
996 ‎‡2  NTA|071884548‏
996 ‎‡2  ISNI|0000000033608558‏
996 ‎‡2  BLBNB|000360682‏
996 ‎‡2  BIBSYS|1542227322921‏
996 ‎‡2  BNF|13999477‏
996 ‎‡2  ISNI|000000004838979X‏
996 ‎‡2  DNB|1219312606‏
996 ‎‡2  J9U|987007350722405171‏
996 ‎‡2  LC|n 50046560‏
996 ‎‡2  CAOONL|ncf10079659‏
996 ‎‡2  NII|DA04291197‏
996 ‎‡2  SUDOC|088521591‏
996 ‎‡2  ISNI|0000000107877604‏
996 ‎‡2  BAV|495_265053‏
996 ‎‡2  BNF|12414825‏
996 ‎‡2  CAOONL|ncf10118056‏
996 ‎‡2  DNB|1161614737‏
996 ‎‡2  PLWABN|9811331653805606‏
996 ‎‡2  SUDOC|077444124‏
996 ‎‡2  ISNI|0000000084127906‏
996 ‎‡2  NUKAT|n 2008155330‏
996 ‎‡2  BIBSYS|90945226‏
996 ‎‡2  NYNYRILM|216428‏
996 ‎‡2  NII|DA01165367‏
996 ‎‡2  SUDOC|18546551X‏
996 ‎‡2  BIBSYS|90672826‏
996 ‎‡2  PTBNP|388152‏
996 ‎‡2  NLA|000035856514‏
996 ‎‡2  SZ|135573513‏
996 ‎‡2  NLA|000035457233‏
996 ‎‡2  BNF|12500126‏
996 ‎‡2  BNF|14132642‏
996 ‎‡2  N6I|vtls000096990‏
996 ‎‡2  BIBSYS|11058055‏
996 ‎‡2  NTA|132867478‏
996 ‎‡2  ISNI|0000000028706807‏
996 ‎‡2  LC|n 80113010‏
996 ‎‡2  RERO|A003752222‏
996 ‎‡2  DNB|173375944‏
996 ‎‡2  BIBSYS|10046882‏
996 ‎‡2  NTA|212843508‏
996 ‎‡2  LC|n 79101275‏
996 ‎‡2  SUDOC|069230331‏
996 ‎‡2  BIBSYS|90257323‏
996 ‎‡2  ISNI|0000000365211362‏
996 ‎‡2  RERO|A000138326‏
996 ‎‡2  NLA|000035947026‏
996 ‎‡2  ISNI|0000000433802253‏
996 ‎‡2  LC|no2019105972‏
996 ‎‡2  ISNI|0000000116727990‏
996 ‎‡2  LC|nb2012006579‏
996 ‎‡2  LC|n 87918100‏
996 ‎‡2  ISNI|0000000497454497‏
996 ‎‡2  LC|nr 95006846‏
996 ‎‡2  SUDOC|076189570‏
996 ‎‡2  SUDOC|125690932‏
996 ‎‡2  ISNI|000000002945682X‏
996 ‎‡2  NUKAT|n 2012156364‏
996 ‎‡2  LC|no2010132805‏
996 ‎‡2  ISNI|000000004721033X‏
996 ‎‡2  NTA|094874352‏
996 ‎‡2  J9U|987007386486005171‏
996 ‎‡2  J9U|987012798439805171‏
996 ‎‡2  BIBSYS|1707990467681‏
996 ‎‡2  LC|no2012101000‏
996 ‎‡2  LIH|LNB:DBV9;=BB‏
996 ‎‡2  J9U|987007350857105171‏
996 ‎‡2  CAOONL|ncf11635370‏
996 ‎‡2  LC|no2016095242‏
996 ‎‡2  ISNI|0000000395039057‏
996 ‎‡2  ISNI|000000006753266X‏
996 ‎‡2  BNF|12171728‏
996 ‎‡2  BNF|16706638‏
996 ‎‡2  SUDOC|257615709‏
996 ‎‡2  J9U|987007605490505171‏
996 ‎‡2  SELIBR|315974‏
996 ‎‡2  LC|n 90634681‏
996 ‎‡2  LC|no2008174138‏
996 ‎‡2  NKC|jn20000604675‏
996 ‎‡2  LC|n 2003079715‏
996 ‎‡2  RERO|A022974779‏
996 ‎‡2  LC|no2024114152‏
996 ‎‡2  ISNI|0000000110615488‏
996 ‎‡2  ISNI|0000000367201619‏
996 ‎‡2  SUDOC|164715150‏
996 ‎‡2  SUDOC|085978728‏
996 ‎‡2  NLA|000036033204‏
996 ‎‡2  ISNI|0000000448820606‏
996 ‎‡2  LC|no 95058483‏
996 ‎‡2  BNF|14458733‏
996 ‎‡2  DNB|130134988‏
996 ‎‡2  ISNI|0000000109123793‏
996 ‎‡2  SUDOC|231978731‏
996 ‎‡2  CAOONL|ncf10104823‏
996 ‎‡2  ISNI|000000003608047X‏
996 ‎‡2  RERO|A025620168‏
996 ‎‡2  NSK|000567798‏
996 ‎‡2  BIBSYS|90154189‏
996 ‎‡2  PTBNP|231789‏
996 ‎‡2  ISNI|0000000384700399‏
996 ‎‡2  NUKAT|n 2013065125‏
996 ‎‡2  NYNYRILM|188946‏
996 ‎‡2  LC|n 2006002015‏
996 ‎‡2  J9U|987007446785905171‏
996 ‎‡2  NII|DA01230571‏
996 ‎‡2  LC|n 88154868‏
996 ‎‡2  LC|n 85084953‏
996 ‎‡2  CAOONL|ncf11422065‏
996 ‎‡2  ISNI|0000000032243227‏
996 ‎‡2  NUKAT|n 2005144778‏
996 ‎‡2  ISNI|000000002934844X‏
996 ‎‡2  LC|n 86015950‏
996 ‎‡2  ISNI|0000000053567060‏
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏